How Does a Cardiologist Keep Heart-Healthy?

As a cardiologist specializing in prevention of heart attack and stroke, you can imagine I try to practice what I preach. Some of this is easy and comes naturally to me. I was always athletic and competed in track and field while in college, which is one of the things that drew me to the study of medicine. But, like most people, I still have to work at maintaining certain healthy lifestyle choices. (more…)

From The Heart: A Cardiologist Shares Simple Advice

Guest post by Jacqueline E. Tamis-Holland, MD, Director, Cardiac Catheterization, Mount Sinai Roosevelt Hospital, and Director, Women’s Heart NY

A love of chemistry and physics led Dr. Jacqueline Tamis-Holland to cardiology — and a love of patient care has kept her there. Leading by example is very important to Dr. Tamis-Holland, who is Site Director of the Cardiac Catheterization Lab  at Mount Sinai Roosevelt Hospital and Director of Women’s Heart NY.

“Many of the risk factors for heart disease can be controlled or even avoided,” says Tamis-Holland. “So there are actually a lot of steps people can take for a healthier heart.” (more…)

Arthur Klein, MD, Named President of The Mount Sinai Health Network

Arthur Klein, MD, a leader in health care management, has been named President of The Mount Sinai Health Network. In this new role, Dr. Klein will oversee The Mount Sinai Medical Center’s growing network of more than one hundred clinical relationships, including eighteen affiliated hospitals, five nursing homes, and twelve physician group practices throughout New York City, and Nassau, Suffolk, and
Westchester counties.

“Dr. Klein is known as an innovator in the evolving health care landscape,” says Kenneth L. Davis, MD, President and Chief Executive Officer of The Mount Sinai Medical Center.  “His leadership will help invigorate and integrate our growing network of hospitals, clinical practices, and polyclinics.”

(more…)

New Myelofibrosis Drug Holds Promise

In a phase I clinical trial, physicians at The Mount Sinai Medical Center have identified the first drug that appears to stop the progression of myelofibrosis, a life-threatening blood cancer. The investigators found that, at low-doses, panobinostat (LBH589) successfully halted and reversed damage to the blood and bone marrow in several of the forty patients enrolled in the trial. Panobinostat, manufactured by Novartis, is a histone deacetylase inhibitor that affects the chromatin structure of malignant cells.

The study, led by Ronald Hoffman, MD, Albert A. and Vera G. List Professor of Medicine, and Director of the Myeloproliferative Disorders Research Program, and John O. Mascarenhas, MD, Assistant Professor of Medicine (Hematology and Medical Oncology), was published online in the January 21, 2013, issue of the British Journal of Haematology.

(more…)

A Cure for One Patient Yields Hope for Others

Two years before seeking help from physicians at The Mount Sinai Medical Center, Rosemary McGinn, 53, was diagnosed with hypoglycemia. She went everywhere with an arsenal of snacks and juices that she ingested frequently to keep her blood sugar from dropping.

“When my sugar would suddenly crash, it was like I was drunk,” she says. “I would become very combative, not knowing what I was saying, and sway back and forth.”

(more…)

Pin It on Pinterest